Limited importance of pre-embryo pronuclear morphology (zygote score) in assisted reproduction outcome in the absence of embryo cryopreservation

2007 ◽  
Vol 88 (4) ◽  
pp. 1167-1173 ◽  
Author(s):  
Alessia Nicoli ◽  
Barbara Valli ◽  
Roberta Di Girolamo ◽  
Barbara Di Tommaso ◽  
Andrea Gallinelli ◽  
...  
2019 ◽  
Vol 31 (12) ◽  
pp. 1753 ◽  
Author(s):  
E. L. Squires

Marked changes in equine breeding technologies have occurred over the past 25 years. Although there have been numerous reviews on assisted reproduction techniques for horses, few publications include the acceptance and impact of these techniques on the horse industry. In this review, several techniques are discussed, with an emphasis on how they developed in the horse industry and altered equine reproductive medicine. Embryo transfer has become a widely used technology, allowing multiple foals to be produced per year. Embryos can be collected, cooled or frozen, and shipped to a distant facility for transfer into recipient mares. Failure to obtain embryos from some mares stimulated the development of oocyte collection and transfer. Oocyte technologies became more practical when intracytoplasmic sperm injection was developed in the early 2000s. There are now facilities across the world that routinely produce embryos invitro. Cryopreservation of oocytes has lagged because of limited success, but embryo cryopreservation is commonplace. Techniques such as sex-sorted semen, superovulation and genetic diagnosis of embryos are not widely used, and they will require more development before they are established in the horse industry in a cost-efficient manner.


2021 ◽  
Vol 03 (03) ◽  
pp. 94-100
Author(s):  
Jennifer K. Y. Ko ◽  
Kevin K.W. Lam ◽  
Heidi H.Y. Cheng ◽  
Man Wa Lui ◽  
Sofie S.F. Yung ◽  
...  

Background: Fertility preservation is increasingly important with improving cancer survival rates and the delay in childbearing in modern societies. The objective of our study was to review the experience of the fertility preservation programme in a tertiary-assisted reproduction unit in Hong Kong. Methods: This is a retrospective study involving men and women who were seen at a tertiary-assisted reproduction unit for fertility preservation counselling before gonadotoxic treatment from January 2005 to December 2020. Their medical records in paper and electronic forms were reviewed. Results: There were 75 consultations for female fertility preservation from 2010 to 2020 involving 72 women. Twenty women underwent 22 cycles of ovarian stimulation for oocyte or embryo cryopreservation, two of whom subsequently transported their oocytes abroad for further management and another two achieved natural conception. Additional four women who did not have oocyte or embryo cryopreservation achieved natural conception after cancer treatment. Eleven (15.2%) women were followed up at a reproductive endocrinology clinic after their cancer treatment. From 2005 to 2020, 265 men had sperm cryopreserved. Twenty-six (9.8%) came back to use the cryopreserved sperms, the wives of 13 (50.0%) of whom achieved an on-going pregnancy. Six of them transferred out and 40 discarded the cryopreserved sperms. Conclusions: There was generally an increasing number of patient consultations for fertility preservation in our Centre over the past decade but a consistently low rate of utilisation of cryopreserved gametes for both women and men. Post-cancer treatment fertility evaluation and monitoring was a major area of deficiency in Hong Kong. More structured post-cancer treatment fertility follow-up is needed.


2017 ◽  
Vol 8 (1) ◽  
pp. 24-31
Author(s):  
PS Divyashree ◽  
Khushboo Priya

ABSTRACT Fertility restoration in cancer patients is gaining a very important role in the field of reproductive medicine, due to the rising incidence of cancer as well as its early detection and improved survival rate. The two options for achieving this aim are ovarian tissue cryopreservation (OTC) and assisted reproductive treatment (ART) through oocyte or embryo cryopreservation after IVF. However, both these have some advantages and disadvantages over each other. OTC is still in experimental phase but is growing faster as an important part of fertility restoration. ART is time tested method which can be relied upon to a great extent, but there are some situations where ART cannot meet the expectations. This review is an overview of the pros and cons of both these options and the status of these methods in the present scenario of fertility preservation. How to cite this article Priya K, Divyashree PS. Restoring Fertility in Cancer Survivors: Ovarian Tissue Cryopreservation or Assisted Reproduction Technique. Int J Infertil Fetal Med 2017;8(1):24-31.


PLoS ONE ◽  
2020 ◽  
Vol 15 (12) ◽  
pp. e0244411
Author(s):  
Jarrod McKenna ◽  
Nadia Bellofiore ◽  
Sally Catt ◽  
Mulyoto Pangestu ◽  
Peter Temple-Smith

The Egyptian or Common spiny mouse (A. cahirinus) is the first rodent species to show human-like menstruation and spontaneous decidualisation. We consider from these, and its other, human-like characteristics that this species will be a more useful and appropriate small animal model for human reproductive studies. Based on this, there is a need to develop specific laboratory-based assisted reproduction protocols including superovulation, in-vitro fertilisation, embryo cryopreservation and transfer to expand and make this model more relevant. Because standard rodent superovulation has not been successful in the spiny mouse, we have selected to test a human protocol. Female spiny mice will receive a subcutaneous GnRH agonist implant and be allowed to recover. Menstrual cycle lengths will then be allowed to stabilize prior to ovarian stimulation. After recovery, females will be injected IP once a day for 4 days with a FSH analogue, to induce follicular growth, and on day 5 will be injected IP with a hCG analogue to trigger ovulation. Females will either be culled 36hrs after trigger to collect oocytes or immediately paired with a stud male and two cell embryos collected 48hrs later. Mature oocytes will be inseminated using fresh spiny mouse spermatozoa and all in-vitro grown and in-vivo collected two cell embryos will be cryopreserved using methods developed in a close spiny mouse relative, the Mongolian gerbil. For embryo transfer, vitrified embryos will be rapidly warmed and non-surgically transferred to surrogate mice. Surrogates will be monitored until pregnancy is apparent (roughly 30 days) and then left undisturbed until birth, 38–40 days after transfer. By successfully developing robust assisted reproduction protocols in A. cahirinus we will be able to use this rodent as a more effective model for human reproduction.


2012 ◽  
Vol 24 (1) ◽  
pp. 139 ◽  
Author(s):  
W. F. Swanson ◽  
H. L. Bateman ◽  
J. Newsom ◽  
V. A. Conforti ◽  
J. R. Herrick ◽  
...  

Domestic cats are invaluable research models for the study of hereditary diseases that affect both cats and humans. By necessity, most cat models are maintained as living populations; however, semen and embryo cryopreservation could provide a cost-effective alternative for model conservation if viable offspring can be readily produced with assisted reproductive techniques such as IVF, embryo transfer (ET) and AI. In our earlier research, semen and IVF-derived embryos representing 24 cat models at 7 veterinary/medical schools were frozen for liquid nitrogen storage. Our objectives in this study were to (1) assess the application of assisted reproduction using frozen semen or embryos for producing pregnancies and viable kittens in several cat models and (2) provide our university collaborators with rederived model offspring. Five cat models (i.e. spinal muscular atrophy, SMA; porphyria, POR; Chediak-Higashi syndrome, CHS; progressive retinal atrophy, PRA; and hypertrophic cardiomyopathy, HCM) were selected for propagation based on investigator research needs. For 3 models (SMA, POR and CHS), semen from affected males, frozen as pellets in Test Egg Yolk medium (with 4% glycerol), was thawed and used to inseminate (5 × 105 motile sperm mL–1) oocytes from eCG/hCG-treated queens. Resulting embryos (2- to 8-cell stage) were transferred laparoscopically (3–5 embryos/recipient) into the oviducts of anestrual queens synchronized with eCG/pLH. For PRA, IVF embryos from affected cats were frozen in 1.5 M ethylene glycol and later thawed for transfer into eCG/pLH-synchronized queens and for HCM, frozen semen from a carrier male was used for laparoscopic oviducal insemination (1 × 106 to 4 × 106 motile sperm/AI) of eCG/pLH-treated females. Ultrasonography was conducted approximately 21 days post-ET or -AI for pregnancy diagnosis. Following IVF with frozen-thawed semen, embryos were produced in all 3 models but overall fertilization success was low (21%, 34/164). All (5/5) recipients became pregnant after ET, giving birth to a total of 11 offspring (6 viable, 5 stillborn). Following frozen ET (PRA), most (3/5) recipients became pregnant with 6 kittens carried to term (3 viable, 3 stillborn), whereas with frozen semen AI (HCM), most (4/7) females conceived with the subsequent birth of 22 kittens (all viable). All surviving offspring (n = 25) for the 5 disease models were distributed to collaborating veterinary schools to reestablish breeding colonies or for ongoing studies. These results indicate that assisted reproduction using frozen semen or embryos may be applied effectively with specific cat models to propagate desired lineages or reestablish research colonies, although some other models have proven more difficult to reproduce. These findings validate our contention that cryopreservation and assisted reproduction may be used to manage and conserve these irreplaceable cat disease models. Funded by NIH grants RR015338, RR02512, HL093603 and HD39888.


2018 ◽  
Vol 36 (05) ◽  
pp. 253-264 ◽  
Author(s):  
Laura Rienzi ◽  
Benedetta Iussig ◽  
Lisa Dovere ◽  
Gemma Fabozzi ◽  
Danilo Cimadomo ◽  
...  

AbstractCryopreserved gametes and embryos are a major feature of human-assisted reproduction and patient care services, accounting for an increasing number of births worldwide. Since the first success obtained using frozen human spermatozoa, cryopreservation technology has been successfully extended to include oocytes and embryos, in a variety of both medical and nonmedical indications. Over the years, the available procedures have become widely implemented and the increasing evidence of its efficacy has contributed to acceptance of the technology. Nevertheless, a gold standard protocol that would be universally shared by clinics has yet to be definitively established and, therefore, research into cryopreservation of gametes and embryos cannot be considered concluded. Moreover, much effort should be committed to the definition and resolution of safety issues, the establishment of automation, and investigations about the potentiality of immature germ cells or stem cells.


2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
János Konc ◽  
Katalin Kanyó ◽  
Rita Kriston ◽  
Bence Somoskői ◽  
Sándor Cseh

Both sperm and embryo cryopreservation have become routine procedures in human assisted reproduction and oocyte cryopreservation is being introduced into clinical practice and is getting more and more widely used. Embryo cryopreservation has decreased the number of fresh embryo transfers and maximized the effectiveness of the IVF cycle. The data shows that women who had transfers of fresh and frozen embryos obtained 8% additional births by using their cryopreserved embryos. Oocyte cryopreservation offers more advantages compared to embryo freezing, such as fertility preservation in women at risk of losing fertility due to oncological treatment or chronic disease, egg donation, and postponing childbirth, and eliminates religious and/or other ethical, legal, and moral concerns of embryo freezing. In this review, the basic principles, methodology, and practical experiences as well as safety and other aspects concerning slow cooling and ultrarapid cooling (vitrification) of human embryos and oocytes are summarized.


Sign in / Sign up

Export Citation Format

Share Document